My clinical interests are centered on the management of thoracic malignancies and head and neck cancers, with a focus on integrating novel therapeutic strategies to improve patient outcomes. As well as early phase studies to test novel approaches in patients with advanced cancer. My research interests lie in translational cancer immunotherapy, early-phase clinical trials, biomarker discovery, and integrative oncology.
Khvaramze Shaverdashvili, MD, PhD
Assistant Professor
Contact Information
Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Assistant Professor
RESEARCH & CLINICAL INTEREST
Education
Medical School
PhD in Biochemistry, Case Western Reserve University, Cleveland
Tbilisi State Medical University, Tbilisi Georgia - 2007
Residency
Internal Medicine Residency, Albert Einstein College of Medicine – Jacobi Medical Center, Bronx, NY - 2019
Fellowship
Hematology & Medical Oncology Fellowship, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA - 2024
Most Recent Peer-Reviewed Publications
- Advances in the treatment of KRASG12C mutant non–small cell lung cancer
- Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis
- Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC
- Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution
- A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2
Board Certifications
American Board of Internal Medicine – Internal Medicine (2019)
ECFMG Certified
Awards
- Selected Participant, AACR/ASCO Methods in Clinical Cancer Research Workshop, 2025
- Clinical and Translational Science Institute (CTSI) TL1 Research Fellowship Award, University of Pittsburgh 2024
- UPMC/UPCI Melanoma and Skin Cancer SPORE Career Enhancement Program Award, 2024
- UPMC Hillman Cancer Center Pilot Award, 2024
- Selected Participant, International Association of Study of Lung Cancer Academy (IASLC) 2023